TGFB1 and graft versus host disease: This finding is in keeping with the established relevance of TGF-β in immune tolerance, and previous seminal work demonstrating the importance of TGF-β pathway mediators in human GVHD.[38] As well, IFN-γ was increased in TOL patients.